survivin在肝癌细胞株Hep G_2表达与化疗药物敏感性的关系  

Relationship between changes of survivin expression and chemotherapeutic sensitivity in Hep G_2

在线阅读下载全文

作  者:梁瑞[1] 孟宏涛[2] 段炜[2] 王家林[1] 李战宁[2] 徐文焕[3] 

机构地区:[1]武警陕西总队医院肝胆胸外科,西安710061 [2]武警陕西总队医院医务处,西安710061 [3]解放军总医院科研处,北京100853

出  处:《武警医学》2015年第8期812-814,共3页Medical Journal of the Chinese People's Armed Police Force

摘  要:目的探讨肝癌细胞株Hep G2中凋亡抑制因子survivin与化疗药物敏感性的关系。方法通过MTT检测肝癌细胞株Hep G2对于1.0μg/ml顺铂,1μmol/L阿霉素,及1.0μg/ml吉西他滨的敏感程度;通过Western blot检测Hep G2中survivin蛋白在顺铂、阿霉素、吉西他滨处理后不同时间段表达水平的变化。结果在药物作用72 h后,10%~20%的肝癌细胞仍然存活并具有代谢活性。顺铂和吉西他滨处理48 h后survivin蛋白表达升高(2.04±0.05 vs 1.25±0.05;1.84±0.02 vs1.25±0.05;1.92±0.05 vs 1.55±0.04;1.88±0.11 vs 1.55±0.04,差异有统计意义(P〈0.05)。阿霉素处理48 h后survivin蛋白表达并未见明显变化(1.73±0.11 vs 1.52±0.02;1.66±0.12 vs 1.52±0.02),差异无统计学意义。结论 survivin蛋白水平升高与肝癌细胞株Hep G2部分化疗药物敏感性相关。Objective To investigate the relationship between survivin and chemotherapeutic sensitivity in hepatocellular carcinoma cells. Methods By the method of MTT,the sensitivity of Hep G2 was tested to be 1. 0 μg / ml cisplatin,1 μmol / L doxorubicin and 1. 0 μg / ml gemcitabine. Western blot was used to detect the expression of survivin protein at various time points after the drugs intervention. Results Cultured for 72 hours,10-20% of Hep G2 cells were still alive( 2. 039 ± 0. 05 vs 1. 258 ± 0. 05; 1. 843 ± 0. 02 vs 1. 258 ± 0. 05; 1. 924 ± 0. 05 vs 1. 551 ± 0. 04; 1. 884 ± 0. 11 vs 1. 551 ± 0. 04),P〈0. 05. After cisplatin and gemcitabine intervention for 48 hours,the expression of survivin was elevated( P〈0. 05). After adriamycin treatment for 48 hours,the expression of survivin protein had no significant change( 1. 729 ± 0. 11 vs 1. 518 ± 0. 02; 1. 667 ± 0. 12 vs 1. 518 ± 0. 02). Conclusions In Hep G2,the high expression of survivin is associated with the chemosensitivities of parts of drugs.

关 键 词:肝癌 SURVIVIN 顺铂 吉西他滨 阿霉素 

分 类 号:R735.7[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象